---
$id: https://graph.org.ai/products/commodity/51241250
$type: Product
source: UNSPSC
code: "51241250"
title: "Motretinide"
class: "51241200"
classTitle: "Dermatologic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Motretinide

**UNSPSC Code**: 51241250
**Class**: [Dermatologic agents](Dermatologic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a retinoic acid agent with the molecular formula C23H31NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W786807KL1, chemically known as 2,4,6,8-nonatetraenamide, n-ethyl-9- (4-methoxy-2,3, 6-trimethylphenyl)-3,7-dimethyl-, (all-e)- but generally known as motretinide, which bears US NIH Compound Identifier 41827. European Medicines Agency schedules Motretinide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09077MIG. The term MOTRETINIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules motretinide in its Anatomical Therapeutic Chemical (ATC) Classification. MOTRETINIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule motretinide under HS 29242995 and SITC 51479. As of Q4 2014, MOTRETINIDE remains the US FDA Preferred Term for this commodity. Motretinide bears US NLM identifiers UMLS ID C0129022 and NCI Concept Code C90940. SMILES: O(C1C(C(C(C(C1)C)/C=C/C(=C/C=C/C(=C/C(=O)NCC)C)C)C)C)C.

